Skip to main content
Premium Trial:

Request an Annual Quote

Microsoft Research, SIB, University of Geneva Start Bioinformatics Collaboration

NEW YORK (GenomeWeb News) – Microsoft Research will work with the Swiss Institute of Bioinformatics and the University of Geneva’s Proteome Informatics Group in a research collaboration that will combine mass spectrometry with an informatics platform aimed at screening human blood for toxic biomarkers, SIB said Friday.
Under the two-year agreement, Microsoft Research will fund the joint development and implementation of a combined software and database platform that can detect the effects of certain drug chemical fragments found in patients’ blood samples through mass spectrometry screening.
SIB said the Biomedical Proteomics Research Group and Geneva Bioinformatics, two of the Proteome Informatics Group’s partners, also will be involved in the collaboration. GeneBio is a private company founded in 1997 to commercialize SIB’s technology, and it also markets its own Phenyx proteomics software.
The collaboration will seek to identify conflicts between different drugs and eventually will attempt to develop technology that can predict how these conflicts may affect patients, particularly cancer patients.
“The multi-disciplinary expertise in medicine, proteomics and bioinformatics … will allow us to move faster in unraveling a currently major problem in prescribing drugs to patients,” SIB Executive Director Ron Appel said in a statement.
Financial terms of the agreement were not released.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.